Cresco Labs (CRLBF) Other financing activities (2020 - 2026)
Cresco Labs' (CRLBF) quarterly Other financing activities came in at -$10000.0 in Q1 2026, up 96.89% YoY from -$5078.9 in Q1 2025, and down 100.07% on a QoQ basis from $14.4 million in Q4 2025.
Cresco Labs (CRLBF) Other financing activities (2020 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 7 years of Other financing activities data on file, last reported at -$10000.0 in Q1 2026.
- Quarterly Other financing activities rose 96.89% year-over-year to -$10000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $323000.0 (up 202.54% YoY) and the FY2025 annual result came in at $11000.0, up 22.22% from the prior year.
- Other financing activities eased to -$10000.0 in Q1 2026, from $14.4 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $14.4 million in Q4 2025 to a low of -$14.2 million in Q3 2025.
- A 5-year average of $230357.1 and a median of $184500.0 in 2022 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 2057.14% in 2025, down 16200.0% in 2025.
- Tracing CRLBF's Other financing activities over 5 years: stood at $218000.0 in 2022, then surged by 793.12% to $1.9 million in 2023, then tumbled by 99.64% to $7000.0 in 2024, then soared by 205314.29% to $14.4 million in 2025, then tumbled by 100.07% to -$10000.0 in 2026.
- The last three Other financing activities figures came in at -$10000.0 (Q1 2026), $14.4 million (Q4 2025), and -$14.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Cresco Labs | 290.46 Mn | 226.34 Mn | 86.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,000.00 |
| Mar 31, 2026 | -10,000.00 |
| Dec 31, 2025 | 14.38 Mn |
| Dec 31, 2025 | 14.38 Mn |
| Sep 30, 2025 | -14.20 Mn |
| Sep 30, 2025 | -14.20 Mn |
| Jun 30, 2025 | 151,000.00 |
| Jun 30, 2025 | 151,000.00 |
| Mar 31, 2025 | -322,000.00 |
| Mar 31, 2025 | -322,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 1.95 Mn |
| Dec 31, 2023 | 1.95 Mn |
| Sep 30, 2023 | -5.67 Mn |
| Sep 30, 2023 | -5.67 Mn |
| Jun 30, 2023 | 3.10 Mn |
| Jun 30, 2023 | 3.10 Mn |